Management Strategies for Patients with Low GFR
Patients with GFR <30 mL/min/1.73 m² require comprehensive monitoring and management of multiple complications to prevent disease progression and improve outcomes. 1, 2
Monitoring and Assessment
- Monitor blood pressure at every clinic visit (at least every three months) for patients with GFR <30 mL/min/1.73 m² 1
- Check serum albumin and body weight every three months to monitor nutritional status 1
- Screen for dyslipidemias by measuring triglycerides, LDL, HDL, and total cholesterol 1
- Evaluate for secondary causes of dyslipidemia including comorbid conditions and medication effects 1
- Monitor serum potassium levels regularly, especially in patients receiving ACE inhibitors, ARBs, or mineralocorticoid receptor antagonists 2, 3
- Consider measuring BNP/NT-proBNP and troponin levels with caution, as interpretation must account for reduced GFR 1
Blood Pressure Management
- Target blood pressure <130/80 mmHg in patients with GFR <30 mL/min/1.73 m² 1
- Use ACE inhibitors or ARBs as first-line agents for hypertension management 1, 3
- Monitor renal function and potassium levels after initiation or dose adjustment of ACE inhibitors or ARBs 3
- Be aware that patients with low GFR may experience hyperkalemia with ACE inhibitors (occurring in approximately 4.8% of heart failure patients) 3
Metabolic Management
- Consider bicarbonate supplementation to maintain serum bicarbonate within normal range for patients with metabolic acidosis 1
- Target LDL cholesterol to <100 mg/dL, non-HDL cholesterol to <130 mg/dL, and treat fasting triglycerides ≥500 mg/dL 1
- Monitor for vitamin D deficiency and consider supplementation if 25(OH) vitamin D levels are <30 ng/mL 1
- Address hypocalcemia (serum calcium <8.5 mg/dL) with elemental calcium supplementation after addressing phosphorus issues 1
Nutritional Management
- Restrict dietary protein to 0.8 g/kg/day for patients with GFR <60 mL/min/1.73 m² and nephrotic-range proteinuria 1, 2
- Avoid protein restriction below 0.6 g/kg/day due to safety concerns and risk of malnutrition 1, 2
- Restrict dietary sodium to <2.0 g/day to reduce edema, control blood pressure, and reduce proteinuria 1, 2
- Target caloric intake of 30-35 kcal/kg/day for patients with GFR <60 mL/min/1.73 m² 1
- Encourage regular physical activity and provide counseling to increase physical activity; refer to physical therapy if mobility is limited 1
Medication Management
- Adjust medication dosages based on GFR levels, particularly for drugs with renal clearance 2, 3
- Avoid nephrotoxic medications (e.g., NSAIDs) in patients with decreased GFR 2
- Consider temporary discontinuation of certain medications during procedures with risk of acute kidney injury 2
- Monitor for drug interactions that may affect renal function or potassium levels 3
Planning for Renal Replacement Therapy (RRT)
- Discuss RRT modality options with patients who have GFR <30 mL/min/1.73 m² 1
- Note that no specific GFR threshold alone should determine when to initiate RRT 1
- Consider initiating RRT in patients with GFR <20 mL/min/1.73 m² who have evidence of malnutrition that does not respond to nutritional intervention 1
- Refer patients willing to have renal transplantation for transplant evaluation 1
- Preserve veins suitable for vascular access placement if hemodialysis is planned 1
- Refer for surgery to construct primary AV fistula if hemodialysis is the chosen modality 1
Employment and Education
- Provide structured education regarding preparation for RRT 1
- Encourage patients to maintain employment and refer to vocational counseling per patient preference 1
Special Considerations and Pitfalls
- Be aware that clinical symptoms and signs are poorly predictive of reduced renal function until GFR falls below 15 mL/min/1.73 m² 4
- Recognize that GFR decline rate (slope) is a strong predictor of progression to kidney failure 5
- Understand that reduced GFR in heart failure patients is mainly dependent on decreased renal blood flow 6
- Consider that patients with low GFRs are generally at increased bleeding risk, and antiplatelet medications further increase this risk 1
- Recognize that elevated troponin in CKD patients has good prognostic accuracy despite reduced diagnostic accuracy for acute coronary syndrome 1